Is N-Cadherin Expression Important in Ductal Carcinoma?
暂无分享,去创建一个
G. Watkins | W. Jiang | S. Ofori-Acquah | L. Shevde | J. King | W. Jiang
[1] W. Jiang,et al. The role of aromatase and 17-β-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer , 2006, Breast Cancer Research and Treatment.
[2] S. Jaffer,et al. N-cadherin Expression in Breast Cancer: Correlation with an Aggressive Histologic Variant – Invasive Micropapillary Carcinoma , 2005, Breast Cancer Research and Treatment.
[3] L. Derycke,et al. N-cadherin in the spotlight of cell-cell adhesion, differentiation, embryogenesis, invasion and signalling. , 2004, The International journal of developmental biology.
[4] G. Watkins,et al. Aberrant expression of interleukin-7 (IL-7) and its signalling complex in human breast cancer. , 2004, European journal of cancer.
[5] G. Watkins,et al. The Hepatocyte Growth Factor Regulatory Factors in Human Breast Cancer , 2004, Clinical Cancer Research.
[6] G. Watkins,et al. Prognostic value of rho GTPases and rho guanine nucleotide dissociation inhibitors in human breast cancers. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[7] R. Walker,et al. Expression of P-cadherin, but not E-cadherin or N-cadherin, relates to pathological and functional differentiation of breast carcinomas , 2003, Molecular pathology : MP.
[8] R. Mansel,et al. Levels of expression of lipoxygenases and cyclooxygenase-2 in human breast cancer. , 2003, Prostaglandins, leukotrienes, and essential fatty acids.
[9] R. Mansel,et al. Expression of peroxisome‐proliferator activated receptor‐gamma (PPARγ) and the PPARγ co‐activator, PGC‐1, in human breast cancer correlates with clinical outcomes , 2003 .
[10] W. Jiang,et al. Lymphangiogenesis quantification using quantitative PCR and breast cancer as a model. , 2001, Biochemical and biophysical research communications.
[11] K Satyamoorthy,et al. N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells. , 2001, Cancer research.
[12] C. Myers,et al. Rho-kinase inhibitor retards migration and in vivo dissemination of human prostate cancer cells. , 2000, Biochemical and biophysical research communications.
[13] Stuart A. Aaronson,et al. Exogenous Expression of N-Cadherin in Breast Cancer Cells Induces Cell Migration, Invasion, and Metastasis , 2000, The Journal of cell biology.
[14] Keith R. Johnson,et al. N-Cadherin Promotes Motility in Human Breast Cancer Cells Regardless of Their E-Cadherin Expression , 1999, The Journal of cell biology.
[15] A. P. Soler,et al. P‐cadherin expression in breast carcinoma indicates poor survival , 1999, Cancer.
[16] I. Nazarenko,et al. A closed tube format for amplification and detection of DNA based on energy transfer. , 1997, Nucleic acids research.
[17] R. Hazan,et al. N-cadherin promotes adhesion between invasive breast cancer cells and the stroma. , 1997, Cell adhesion and communication.
[18] R. Mansel,et al. Levels of expression of endothelial markers specific to tumour-associated endothelial cells and their correlation with prognosis in patients with breast cancer , 2004, Clinical & Experimental Metastasis.
[19] R. Mansel,et al. Expression of peroxisome-proliferator activated receptor-gamma (PPARgamma) and the PPARgamma co-activator, PGC-1, in human breast cancer correlates with clinical outcomes. , 2003, International journal of cancer.
[20] Troy Stevens,et al. Open Access Activated Leukocyte Cell Adhesion Molecule in Breast Cancer: Prognostic Indicator , 2022 .